Cure8 research brief
Patients with IBD receiving biologic therapy need regular lab monitoring, TB screening, vaccinations, and bone-density assessment; many of these services were underused before the dashboard. Tools that improve those process measures can reduce gaps in recommended care.
Clinicians; clinic quality-improvement teams; patients on biologic therapy; adult patients with IBD
A 12-week Plan-Do-Study-Act project at a veterans' clinic used an electronic dashboard to identify overdue health-maintenance items for patients receiving biologics.
Before the intervention, rates of recommended monitoring and prevention were incomplete (laboratory monitoring 67%, bone density 46%, TB screening 54%, pneumococcal vaccination 33%, influenza vaccination 63%).
After implementing the dashboard, the reported rates rose substantially (laboratory monitoring 96%, bone density 96%, TB screening 96%, pneumococcal 78%, influenza 78%). The report frames dashboards as a practical clinic tool to help teams close gaps in preventive care and monitoring for immunosuppressed patients.
It does not provide patient-level outcomes or long-term follow-up, but it documents improved process metrics over the 12-week project period.
This is a 12-week quality-improvement project reported as an abstract-style article. The findings describe process improvements (monitoring and vaccination rates) over a short period and do not report clinical outcomes or longer-term durability.
Details on the dashboard technology, workflow changes, and generalizability beyond the veterans' clinic setting are limited in the supplied text.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
PROM completion is important for monitoring symptoms and disease control between visits. The study shows a single empowerment campaign produced a short‑term boost in PROM response but not sustained engagement,...
This survey shows IUS is increasingly recognized but underutilized in China due to limited training and varied perceptions across specialties; patients generally like IUS but many have safety concerns. Addressing...
An AI-derived score that combines inflammation severity and extent may better predict relapse risk in ulcerative colitis than severity alone. That could help identify patients in endoscopic remission who still face...
